Page last updated: 2024-11-05

tetralin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetralin, also known as 1,2,3,4-tetrahydronaphthalene, is a colorless liquid hydrocarbon. It is a cyclic compound with four carbon atoms in a ring and four hydrogen atoms attached to each carbon. Tetralin is used as a solvent, a fuel additive, and a starting material for the synthesis of other chemicals. It is also a component of some types of coal tar. Tetralin is a relatively stable compound, but it can be oxidized to form naphthalene. Tetralin is an important component of jet fuel and is studied for its potential use as a renewable energy source. It is a valuable intermediate in the production of various chemicals, including pharmaceuticals and agrochemicals. Tetralin is also a model compound used in studies of the chemical and physical properties of aromatic hydrocarbons.'

tetralin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tetralin : An ortho-fused bicyclic hydrocarbon that is 1,2,3,4-tetrahydro derivative of naphthalene. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8404
CHEMBL ID1575635
CHEBI ID35008
MeSH IDM0250754

Synonyms (74)

Synonym
1,2,3,4-tetrahydro-naphthalene
NCIOPEN2_000650
naphthalene 1,2,3,4-tetrahydride
tetralene
CHEBI:35008 ,
nsc-77451
.delta.(sup 5,9)-naphthantriene
tetranap
1,3,4-tetrahydronaphthalene
tetralin
nsc77451
naphthalene 1,3,4-tetrahydride
benzocyclohexane
tetraline
tetrahydronaphthalene
bacticin
wln: l66 & tj
tetralina
naphthalene, 1,2,3,4-tetrahydro-
inchi=1/c10h12/c1-2-6-10-8-4-3-7-9(10)5-1/h1-2,5-6h,3-4,7-8h
119-64-2
1,2,3,4-tetrahydronaphthalene
NCGC00091744-01
einecs 204-340-2
caswell no. 842a
tetralina [polish]
hsdb 127
nsc 77451
epa pesticide chemical code 055901
ai3-01257
delta(sup 5,7,9)-naphthantriene
ccris 3564
1,2,3,4-tetrahydronaphthalene, anhydrous, 99%
.delta.(sup 5,7,9)-naphthantriene
BMSE000530
tetralin solvent
FT-0654145
T0713
T0107
AKOS000121383
NCGC00091744-02
cas-119-64-2
tox21_303325
dtxsid1026118 ,
dtxcid306118
NCGC00256948-01
tox21_201793
NCGC00259342-01
einecs 270-178-4
68412-24-8
naphthalene, tetrahydro-
ec 204-340-2
unii-ft6xmi58yq
ft6xmi58yq ,
STL264224
tetralin [mi]
tetralin [hsdb]
tetralin [usp-rs]
tetralin [who-dd]
CHEMBL1575635
5,6,7,8-tetrahydronaphthalene
1,2,3,4-tetrahydronapthalene
.delta.(5,7,9)-naphthantriene
naphthalene-1,2,3,4-tetrahydride
W-108503
mfcd00001733
F1908-0164
1,2,3,4-tetrahydronaphthalene, analytical standard
1,2,3,4-tetrahydronaphthalene, reagentplus(r), 99%
1,2,3,4-tetrahydronaphthalene, reagent grade, >=97%
1,2,3,4-tetrahydronaphthalene, vetec(tm) reagent grade, 98%
Q420416
1,2,3,4 tetrahyclronaphthalene
EN300-21134

Research Excerpts

Bioavailability

2-alkoxycarbonylamino substituted tetralin carboxamides are potent, selective, and orally bioavailable GHS-R antagonists.

ExcerptReferenceRelevance
" Potent, selective, and orally bioavailable tetralin carboxamide growth hormone secretagogue receptor (GHS-R) antagonists were discovered."( Discovery of tetralin carboxamide growth hormone secretagogue receptor antagonists via scaffold manipulation.
Collins, CA; Falls, HD; Kaszubska, W; Liu, G; Schaefer, VG; Sham, HL; Xin, Z; Zhao, H, 2004
)
0.95
" It was found that certain 2-alkoxycarbonylamino substituted tetralin carboxamides are potent, selective, and orally bioavailable GHS-R antagonists."( Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
Collins, CA; Falls, HD; Kaszubska, W; Liu, B; Liu, G; Nelson, LT; Patel, JR; Schaefer, VG; Sham, HL; Szczepankiewicz, BG; Xin, Z; Zhao, H, 2005
)
0.83
" One of these compounds, 13g, shows modest oral bioavailability in rats."( A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
Askew, BC; Biddlecome, G; Biswas, K; Chen, JJ; D'Amico, DC; Fotsch, C; Groneberg, RD; Han, NB; Hsieh, FY; Johnson, E; Kamassah, A; Kumar, G; Lester-Zeiner, D; Liu, Q; Mareska, DA; Ng, G; Riahi, BB; Wang, YJ; Yang, K; Zhan, J; Zhu, J, 2006
)
0.56
" Some of these compounds showed modest oral bioavailability in rats."( Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
Arik, L; Askew, BC; Biddlecome, G; Biswas, K; Chen, JJ; Fotsch, C; Han, N; Hungate, RW; Johnson, E; Kumar, G; Lester-Zeiner, D; Li, A; Liu, Q; Ng, GY; Qian, W; Yuan, C, 2010
)
0.65
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
ortho-fused bicyclic hydrocarbon
tetralinsCompounds containing a tetralin skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.81070.001318.074339.8107AID926; AID938
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.79220.000214.376460.0339AID720692
estrogen nuclear receptor alphaHomo sapiens (human)Potency49.98640.000229.305416,493.5996AID743075; AID743077
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency62.37600.001723.839378.1014AID743083
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.30600.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1145576Octanol-water partition coefficient, log P of the compound1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Partition coefficients and surface areas of some alkylbenzenes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (85)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (18.82)18.7374
1990's4 (4.71)18.2507
2000's29 (34.12)29.6817
2010's34 (40.00)24.3611
2020's2 (2.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.03 (24.57)
Research Supply Index4.48 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index83.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.15%)6.00%
Case Studies1 (1.15%)4.05%
Observational0 (0.00%)0.25%
Other85 (97.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]